Positive DSMB Review for Masupirdine Phase 3 Study
Suven Life Sciences Limited · SUVEN · NSE ·
An independent Data and Safety Monitoring Board (DSMB) has recommended that the global Phase 3 study of Masupirdine continue as planned without modification. The recommendation follows a positive safety review and a pre-specified interim analysis, with no safety concerns identifi…